Page 7 of articles about vaccine
Pirbright, ECO Animal Health, The Vaccine Group to develop new PRRS vaccines
Pharmgate: PRRSGard® vaccine now available in U.S. market
Modified-live PRRS vaccine has innovative chimeric construction.
Ceva opens new reference for autogenous vaccine manufacture
Ceva builds on its preventative health strategy with the opening of a new European reference for the manufacture of autogenous vaccines.
Hipradermic® 3.0: It’s time to feel the comfort
Hipra has just launched its Hipradermic® 3.0 device, a new and improved version of Hipradermic®: an intradermal needle-free jet injector for the vaccination of pigs.
The Roslin Institute: Stem cell approach to aid vaccine development
Method of producing blood cells will provide platform to aid development of vaccines against deadly infections in pigs such as ASF and PRRS.
Russia discusses developing an ASF vaccine
Reproductive performance of influenza A virus infected sows before and after vaccination
US: APHIS to invest $27 million in foot-and-mouth disease vaccine in case of outbreak
PCV-2d, PCV-2b, PCV-2a. How important are the differences between genotypes for veterinarians?
Serious problems occurred much less frequently with genotype a than with genotype b. Why did the frequency of these genotypes change?
Boehringer Ingelheim’s classical swine fever live vaccine approved
Ingelvac® CSF MLV, the first classical swine fever live vaccine jointly developed by a multinational company and Chinese research institutes.
Pirbright ASF vaccine protects pigs from developing severe disease
100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus.
PRRS - Why can't I achieve long-term stability on my farm?
Its high survivability in the environment, a long infective period, limited cross-protection, strains with different pathogenicity, and lateral infections make stabilization difficult.
What can we expect from the new ASF vaccine developed in China?
This vaccine looks promising, but... are we going to see it in Europe?
Pirbright shows new Nipah vaccines create ‘impressive’ immune response
Two new potential vaccines against Nipah virus developed by the University of Parma generate a strong immune response in pigs, and could be the key to preventing this deadly, zoonotic disease.